Cyclin-dependent kinase inhibitor 2A [CDKN2A] gene and cyclin-dependent kinase 4 (CDK4) gene germline mutations, among other less commonly known mutations, are frequently identified genetic abnormalities in familial melanomas [5,6]. The gene discussed is CDKN2A; the disease is melanoma.